Johnson & Johnson Liability, Defined Benefit Plan, Noncurrent
Johnson & Johnson (JNJ) had Liability, Defined Benefit Plan, Noncurrent of $6.96 billion as of 2025-12-28, per its 10-K filed 2026-02-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent · last filed 2026-02-11
- 2025-12-28: Liability, Defined Benefit Plan, Noncurrent $6.96B.
- 2024-12-29: Liability, Defined Benefit Plan, Noncurrent $7.25B.
- 2023-12-31: Liability, Defined Benefit Plan, Noncurrent $7.15B.
- 2023-01-01: Liability, Defined Benefit Plan, Noncurrent $6.54B; Liability, Defined Benefit Plan, Noncurrent as first filed $6.77B.
| Period end | Liability, Defined Benefit Plan, Noncurrent | Liability, Defined Benefit Plan, Noncurrent as first filed |
|---|---|---|
| 2025-12-28 | $6.96B 10-K · filed 2026-02-11 | |
| 2024-12-29 | $7.25B 10-K · filed 2026-02-11 | |
| 2023-12-31 | $7.15B 10-K · filed 2025-02-13 | |
| 2023-01-01 | $6.54B 10-K · filed 2024-02-16 | $6.77B 10-K · filed 2023-02-16 |
| 2022-01-02 | $8.90B 10-K · filed 2023-02-16 | |
| 2021-01-03 | $10.77B 10-K · filed 2022-02-17 | |
| 2019-12-29 | $10.66B 10-K · filed 2021-02-22 | |
| 2018-12-30 | $9.95B 10-K · filed 2020-02-18 | |
| 2017-12-31 | $10.07B 10-K · filed 2019-02-20 | |
| 2017-04-02 | $9.61B 10-Q · filed 2017-05-08 | |
| 2017-01-01 | $9.62B 10-K · filed 2018-02-21 | |
| 2016-10-02 | $8.22B 10-Q · filed 2016-11-04 | |
| 2016-07-03 | $8.36B 10-Q · filed 2016-08-04 | |
| 2016-04-03 | $8.59B 10-Q · filed 2016-05-10 | |
| 2016-01-03 | $8.85B 10-K · filed 2017-02-27 | |
| 2015-09-27 | $9.52B 10-Q · filed 2015-10-30 | |
| 2015-06-28 | $9.63B 10-Q · filed 2015-07-31 | |
| 2015-03-29 | $9.75B 10-Q · filed 2015-05-01 | |
| 2014-12-28 | $9.97B 10-K · filed 2016-02-24 | |
| 2014-09-28 | $7.55B 10-Q · filed 2014-10-30 | |
| 2014-06-29 | $7.63B 10-Q · filed 2014-08-01 | |
| 2014-03-30 | $7.70B 10-Q · filed 2014-05-02 | |
| 2013-12-29 | $7.78B 10-K · filed 2015-02-24 | |
| 2013-09-29 | $9.04B 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $9.00B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $8.98B 10-Q · filed 2013-05-03 | |
| 2012-12-30 | $9.08B 10-K · filed 2014-02-21 | |
| 2012-09-30 | $7.90B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $8.18B 10-Q · filed 2012-08-02 | |
| 2012-04-01 | $8.24B 10-Q · filed 2012-05-07 | |
| 2012-01-01 | $8.35B 10-K · filed 2013-02-22 | |
| 2011-10-02 | $6.21B 10-Q · filed 2011-11-08 | |
| 2011-07-03 | $6.20B 10-Q · filed 2011-08-09 | |
| 2011-04-03 | $6.13B 10-Q · filed 2011-05-10 | |
| 2011-01-02 | $6.09B 10-K · filed 2012-02-23 | |
| 2010-10-03 | $6.41B 10-Q · filed 2010-11-10 | |
| 2010-07-04 | $6.32B 10-Q · filed 2010-08-11 | |
| 2010-04-04 | $6.25B 10-Q · filed 2010-05-10 | |
| 2010-01-03 | $6.77B 10-K · filed 2011-02-25 | |
| 2008-12-28 | $7.79B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |